IMNN (Imunon) Net Margin %: 0.00% (As of Mar. 2026)


IMNN Imunon Inc IMNN
26 GF Score
Price $1.78
! 2 Warning Signs
View Full Analysis

What is Imunon Net Margin %?

Imunon IMNN 26 Net Margin % is 0.00% as of Mar. 2026. GuruFocus rates IMNN with a GF Score™ of 26/100. The stock has 2 warning signs investors should review. Among 947 Biotechnology companies, Imunon ranks worse than 105596.52% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Imunon's Net Income for the three months ended in Mar. 2026 was $-4.25 Mil. Imunon's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Imunon's net margin for the quarter that ended in Mar. 2026 was 0.00%.

The historical rank and industry rank for Imunon's Net Margin % or its related term are showing as below:


IMNN's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -89.56
* Ranked among companies with meaningful Net Margin % only.

Imunon  (NAS:IMNN) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Imunon Net Margin % Related Terms

Imunon Net Margin % Historical Data

* Premium members only.

The historical data trend for Imunon's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Imunon Net Margin % Chart

Imunon Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4,153.80 -7,179.60 0.00 0.00 0.00

Imunon Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

IMNN vs PMCB, CURX, LABT: Net Margin % Comparison

For the Biotechnology subindustry, Imunon's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Imunon Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Imunon's Net Margin % distribution charts can be found below:

* The bar in red indicates where Imunon's Net Margin % falls into.


IMNN
26GF Score
Imunon Inc IMNN
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Imunon Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Imunon's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-14.495/0
= %

Imunon's Net Margin for the quarter that ended in Mar. 2026 is calculated as

Net Margin=Net Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-4.249/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Imunon (IMNN) has a Net Margin % of 0.00% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Imunon and its competitors. According to the industry distribution chart, Imunon ranks #999999 out of 947 companies in the Biotechnology industry.
Is Imunon's Net Margin % too high?
Imunon's current Net Margin % is 0.00%. Based on the distribution chart, Imunon ranks #999999 out of 947 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Imunon has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Imunon's Net Margin % compare to PMCB and CURX?
According to the Biotechnology industry distribution chart, Imunon ranks #999999 out of 947 companies for Net Margin %. This places Imunon in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Imunon and its competitors. Imunon's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imunon stock overvalued right now?
Imunon (IMNN) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Imunon's overall GF Score™ is 26/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Imunon (IMNN), the current Net Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Imunon Business Description

Other Exchanges CBO0:Germany
Address 997 Lenox Drive, Suite 100, Lawrenceville, NJ, USA, 08648
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit an immunological response. The company's clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer.
26GF Score

Get the complete analysis for IMNN

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.78
Price